About this webinar Recent advances in ulcerative colitis drug development…
About this webinar
Recent advances in ulcerative colitis drug development have opened new therapeutic perspectives. This webinar brings together leading experts to discuss the latest phase 3 results with Obefazimod and explore future directions, including subgroup outcomes and combination therapy potential.
Recipients
General Surgery, Gastroenterology, General Medicine (Family Doctors), Nuclear Medicine, Diagnostic Radiology, Biologist, Nurse
discover the programWebinar speaker
Sponsored by
Organizing Secretariat
Materia Prima is the organizing secretariat of the
webinar and is available for any inquiries.
Do you need some information?
Contact us
- segreteria@materia1a.it
- +39 0363 184 8776